ENCOMPASS HEALTH CORP (EHC) Stock Overview
USA - NYSE:EHC - US29261A1007 - Common Stock
EHC Key Statistics, Chart & Performance
The current stock price of EHC is 126.77 USD. In the past month the price increased by 3.75%. In the past year, price increased by 32.04%.
EHC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 17.1 | 95.81B | ||
| THC | TENET HEALTHCARE CORP | 13.09 | 17.06B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.35 | 12.39B | ||
| ENSG | ENSIGN GROUP INC/THE | 27.84 | 9.62B | ||
| SGRY | SURGERY PARTNERS INC | 25.92 | 2.79B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 16.87 | 2.66B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 7.92 | 2.03B | ||
| PACS | PACS GROUP INC | 17 | 2.00B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.98B | ||
| NHC | NATIONAL HEALTHCARE CORP | 18.29 | 1.90B | ||
| ARDT | ARDENT HEALTH INC | 7.39 | 1.89B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 11.84 | 1.56B |
Related stock screener links
About EHC
Company Profile
Encompass Health Corp. engages in the provision of post-acute healthcare services. The company is headquartered in Birmingham, Alabama and currently employs 23,564 full-time employees. The firm provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. The company operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. The company operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Company Info
ENCOMPASS HEALTH CORP
9001 Liberty Pkwy
Birmingham ALABAMA 35242 US
CEO: Mark J. Tarr
Employees: 23564
Phone: 12059677116
ENCOMPASS HEALTH CORP / EHC FAQ
What is the stock price of ENCOMPASS HEALTH CORP today?
The current stock price of EHC is 126.77 USD. The price increased by 0.58% in the last trading session.
What is the ticker symbol for ENCOMPASS HEALTH CORP stock?
The exchange symbol of ENCOMPASS HEALTH CORP is EHC and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is EHC stock listed?
EHC stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ENCOMPASS HEALTH CORP stock?
17 analysts have analysed EHC and the average price target is 139.74 USD. This implies a price increase of 10.23% is expected in the next year compared to the current price of 126.77. Check the ENCOMPASS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENCOMPASS HEALTH CORP worth?
ENCOMPASS HEALTH CORP (EHC) has a market capitalization of 12.77B USD. This makes EHC a Large Cap stock.
How many employees does ENCOMPASS HEALTH CORP have?
ENCOMPASS HEALTH CORP (EHC) currently has 23564 employees.
What are the support and resistance levels for ENCOMPASS HEALTH CORP (EHC) stock?
ENCOMPASS HEALTH CORP (EHC) has a support level at 126.06 and a resistance level at 126.78. Check the full technical report for a detailed analysis of EHC support and resistance levels.
Is ENCOMPASS HEALTH CORP (EHC) expected to grow?
The Revenue of ENCOMPASS HEALTH CORP (EHC) is expected to grow by 10.96% in the next year. Check the estimates tab for more information on the EHC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ENCOMPASS HEALTH CORP (EHC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EHC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EHC, evaluating the profitability, health, valuation and growth aspects
- ENCOMPASS HEALTH CORP (EHC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENCOMPASS HEALTH CORP (EHC) Sales and EPS estimates to see what analysts future expectations are.
- ENCOMPASS HEALTH CORP (EHC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENCOMPASS HEALTH CORP (EHC) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENCOMPASS HEALTH CORP (EHC) Stock Chart to make your own analysis
- ENCOMPASS HEALTH CORP (EHC) Latest news and press-releases to stay up to date.
Does ENCOMPASS HEALTH CORP (EHC) stock pay dividends?
ENCOMPASS HEALTH CORP (EHC) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.62. Check the full fundamental report for a detailed analysis of EHC dividend history, reliability and sustainability.
When does ENCOMPASS HEALTH CORP (EHC) report earnings?
ENCOMPASS HEALTH CORP (EHC) will report earnings on 2025-10-27, after the market close.
What is the Price/Earnings (PE) ratio of ENCOMPASS HEALTH CORP (EHC)?
The PE ratio for ENCOMPASS HEALTH CORP (EHC) is 25.51. This is based on the reported non-GAAP earnings per share of 4.97 and the current share price of 126.77 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHC.
What is the Short Interest ratio of ENCOMPASS HEALTH CORP (EHC) stock?
The outstanding short interest for ENCOMPASS HEALTH CORP (EHC) is 1.3% of its float. Check the ownership tab for more information on the EHC short interest.
EHC Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to EHC. When comparing the yearly performance of all stocks, EHC is one of the better performing stocks in the market, outperforming 78.2% of all stocks.
EHC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EHC. EHC has an excellent profitability rating, but there are some minor concerns on its financial health.
EHC Financial Highlights
Over the last trailing twelve months EHC reported a non-GAAP Earnings per Share(EPS) of 4.97. The EPS increased by 23.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.18% | ||
| ROA | 7.67% | ||
| ROE | 22.82% | ||
| Debt/Equity | 1.02 |
EHC Forecast & Estimates
17 analysts have analysed EHC and the average price target is 139.74 USD. This implies a price increase of 10.23% is expected in the next year compared to the current price of 126.77.
For the next year, analysts expect an EPS growth of 19.3% and a revenue growth 10.96% for EHC